These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8601679)

  • 21. Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.
    Strydom K; Ismail F; Matabane MM; Onwuegbuna O; Omar SV; Ismail N
    J Clin Microbiol; 2015 Sep; 53(9):3032-4. PubMed ID: 26135869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multidrug-resistant tuberculosis. Remarks and reflections on a controversial subject of current utmost importance].
    Ausina V
    Med Clin (Barc); 1996 Jan; 106(1):15-8. PubMed ID: 8750536
    [No Abstract]   [Full Text] [Related]  

  • 23. Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.
    Hillemann D; Haasis C; Andres S; Behn T; Kranzer K
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29593055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico.
    Amaya-Tapia G; Martín-Del Campo L; Aguirre-Avalos G; Portillo-Gómez L; Covarrubias-Pinedo A; Aguilar-Benavides S
    Microb Drug Resist; 2000; 6(2):143-5. PubMed ID: 10990269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid-resistant disseminated Mycobacterium tuberculosis in a Jamaican infant with HIV/AIDS.
    Singh-Minott I; Pierre RB; Olugbuyi O; Dunkley-Thompson J; Haughton D; Christie CD
    West Indian Med J; 2008 Jun; 57(3):298-301. PubMed ID: 19583132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GenoType  MTBDR assay for detection of rifampicin and isoniazid resistance.
    Wiwanitkit V
    Indian J Med Microbiol; 2015; 33(1):147. PubMed ID: 25560021
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of drug resistance on the generation of secondary cases of tuberculosis.
    Burgos M; DeRiemer K; Small PM; Hopewell PC; Daley CL
    J Infect Dis; 2003 Dec; 188(12):1878-84. PubMed ID: 14673768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
    Nolan CM; Williams DL; Cave MD; Eisenach KD; el-Hajj H; Hooton TM; Thompson RL; Goldberg SV
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1067-71. PubMed ID: 7663785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z; Zhang J; Song H; Zhang X; Li Y; Tian M; Liu Y; Zhao Y; Li C
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment duration for patients with drug-resistant tuberculosis, United States.
    Winston CA; Mitruka K
    Emerg Infect Dis; 2012 Jul; 18(7):1201-2. PubMed ID: 22709909
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation.
    Nikolayevsky V; Brown T; Balabanova Y; Ruddy M; Fedorin I; Drobniewski F
    J Clin Microbiol; 2004 Oct; 42(10):4498-502. PubMed ID: 15472300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods.
    Nachamkin I; Kang C; Weinstein MP
    Clin Infect Dis; 1997 May; 24(5):894-900. PubMed ID: 9142789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive.
    Rouzaud F; Robledo J
    Indian J Med Microbiol; 2010; 28(4):412-3. PubMed ID: 20966587
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid molecular detection of tuberculosis.
    Bhanot N
    N Engl J Med; 2011 Jan; 364(2):183; author reply 184-5. PubMed ID: 21226595
    [No Abstract]   [Full Text] [Related]  

  • 40. [Emerging and drug-resistant infectious diseases--multi-drug resistant tuberculosis].
    Yano I
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2095-102. PubMed ID: 9480316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.